Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of 131I.
Zhu
Rui-Sen
RS
Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200233, China. zhurs33@hotmail.com
Yu
Yong-li
YL
Lu
Han-kui
HK
Luo
Quan-yong
QY
Chen
Li-bo
LB
D018263:Adenocarcinoma, Follicular / Q000532:radiotherapy* / Q000556:secondary; D000293:Adolescent; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000556:secondary; D002291:Carcinoma, Papillary / Q000532:radiotherapy* / Q000556:secondary; D002648:Child; D002869:Chromosome Aberrations / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007011:Hypoparathyroidism / Q000209:etiology; D007457:Iodine Radioisotopes / Q000008:administration & dosage*; D008168:Lung / Q000503:physiopathology; D008175:Lung Neoplasms / Q000556:secondary; D008207:Lymphatic Metastasis; D008875:Middle Aged; D010280:Parathyroid Glands / Q000503:physiopathology; D012469:Salivary Glands / Q000503:physiopathology; D013964:Thyroid Neoplasms / Q000235:genetics / Q000473:pathology* / Q000532:radiotherapy*
D007457:Iodine Radioisotopes